Form 4: Moderna President Stephen Hoge Reports Stock Transactions

Moderna's President, Stephen Hoge, reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.

Summary

• Stephen Hoge, President of Moderna, Inc., filed a Form 4 detailing changes in beneficial ownership.
• On August 30, 2024, 652 restricted stock units (RSUs) vested and converted into common stock.
• Also on August 30, 2024, Hoge acquired 652 shares of common stock upon the vesting of RSUs.
• On September 3, 2024, Hoge sold 318 shares at $76.989 per share to cover tax withholding obligations related to the vesting of RSUs.
• Following these transactions, Hoge directly owns 1,443,002 shares of Moderna common stock.
• Hoge also indirectly owns 4,116 shares through Valhalla, LLC and 151,933 shares through a trust for the benefit of his spouse and children.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Industry Context

This filing is a routine disclosure of stock transactions by a company executive, which is common for publicly traded companies like Moderna. It provides transparency into the trading activities of insiders.

Comparison to Industry Standards

• Executive stock transactions are a normal part of compensation for publicly traded companies.
• Similar filings are made by executives at companies like Pfizer, BioNTech, and Johnson & Johnson.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the sale of shares, but the overall impact is likely minimal.

Key Dates